Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$310.19 - $376.2 $1.55 Million - $1.88 Million
-5,010 Closed
0 $0
Q2 2021

Sep 21, 2023

SELL
$262.71 - $351.17 $5.73 Million - $7.66 Million
-21,810 Reduced 81.32%
5,010 $1.56 Million
Q2 2021

Aug 16, 2021

BUY
$262.71 - $351.17 $1.32 Million - $1.76 Million
5,010 New
5,010 $1.56 Million
Q1 2021

May 14, 2021

SELL
$285.92 - $355.13 $7.67 Million - $9.52 Million
-26,820 Closed
0 $0
Q4 2020

Sep 21, 2023

BUY
$251.88 - $324.2 $6.76 Million - $8.7 Million
26,820 New
26,820 $8.7 Million
Q4 2020

Feb 16, 2021

BUY
$251.88 - $324.2 $4.77 Million - $6.13 Million
18,920 Added 239.49%
26,820 $8.7 Million
Q3 2020

Nov 13, 2020

BUY
$255.22 - $317.0 $2.02 Million - $2.5 Million
7,900 New
7,900 $2.19 Million
Q2 2020

Aug 14, 2020

SELL
$141.4 - $257.09 $704,879 - $1.28 Million
-4,985 Closed
0 $0
Q1 2020

Nov 24, 2020

BUY
$130.51 - $196.01 $650,592 - $977,109
4,985 New
4,985 $743,000
Q1 2020

May 15, 2020

SELL
$130.51 - $196.01 $1.12 Million - $1.68 Million
-8,557 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$159.31 - $223.54 $915,395 - $1.28 Million
5,746 Added 204.41%
8,557 $1.46 Million
Q3 2019

Nov 13, 2019

BUY
$175.89 - $279.23 $494,426 - $784,915
2,811 New
2,811 $500,000
Q2 2019

Aug 14, 2019

SELL
$250.96 - $284.94 $250,960 - $284,940
-1,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$276.39 - $362.25 $276,390 - $362,250
1,000 New
1,000 $286,000
Q4 2018

Feb 14, 2019

SELL
$281.08 - $444.25 $6.37 Million - $10.1 Million
-22,657 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$354.53 - $449.75 $4.78 Million - $6.06 Million
-13,485 Reduced 37.31%
22,657 $10.2 Million
Q2 2018

Aug 14, 2018

BUY
$278.07 - $446.21 $6.98 Million - $11.2 Million
25,115 Added 227.76%
36,142 $14.8 Million
Q1 2018

May 15, 2018

BUY
$192.49 - $295.85 $2.12 Million - $3.26 Million
11,027 New
11,027 $3.21 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.